Clinical trial
Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in…
NCT07025824 · Technische Universität Dresden, Other · Not yet recruiting
Key facts
| NCT number | NCT07025824 |
|---|---|
| Title | Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation |
| Official title | Randomized Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation |
| Acronym | RELEVANT |
| Lead sponsor | Technische Universität Dresden, Other |
| Collaborators | medac GmbH Industry |
| Status | Not yet recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome) |
| Intervention type | Drug |
| Interventions | Treosulfan (Treo), Melphalan (Mel), Fludarabine (Flud) |
| Enrollment | 220 |
| Start date | Sep 1, 2025 |
| Primary completion | Dec 1, 2028 |
| Completion | Dec 1, 2028 |
| First posted | Jun 18, 2025 |
| Last update posted | Sep 3, 2025 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: